Insmed Inc (INSM)vsVeru Inc (VERU)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
VERU
Veru Inc
$2.29
0.00%
HEALTHCARE · Cap: $36.76M
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 3491% more annual revenue ($606.42M vs $16.89M). VERU leads profitability with a 0.0% profit margin vs -2.1%. INSM appears more attractively valued with a PEG of 1.09. VERU earns a higher WallStSmart Score of 41/100 (D).
INSM
Hold39
out of 100
Grade: F
VERU
Hold41
out of 100
Grade: D
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Reasonable price relative to book value
18.3% revenue growth
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : VERU
The strongest argument for VERU centers on Price/Book, Revenue Growth. Revenue growth of 18.3% demonstrates continued momentum.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : VERU
The primary concerns for VERU are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while VERU is a growth play — different risk/reward profiles.
INSM carries more volatility with a beta of 1.17 — expect wider price swings.
VERU is growing revenue faster at 18.3% — sustainability is the question.
VERU generates stronger free cash flow (-6M), providing more financial flexibility.
Bottom Line
VERU scores higher overall (41/100 vs 39/100) and 18.3% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Veru Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. The company is headquartered in Miami, Florida.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?